USPTO serial 79287879
FARMABIOS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 16, 2021
- Examiner
- BRADLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with FARMABIOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael N. Mercanti
Michael N. Mercanti LUCAS & MERCANTI, LLP100 South Jefferson Road, Suite 202Whippany, NJ 07981United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-inflammatory preparations; cholesterol reducers; steroids; respiratory stimulants; cardiotonic; chemotherapeutics; chemico-pharmaceutical preparations for the treatment of autoimmune disorders, inflammations, asthma, psoriasis, cancer, dermatitis; pharmaceuticals for the treatment of autoimmune disorders, inflammations, asthma, psoriasis, cancer and dermatitis | ACTIVE | — |
| 042 | Analysis and evaluation of product development; scientific analysis in the field of pharmaceuticals, active pharmaceutical ingredients, drug substances; chemistry consultation; consultancy relating to pharmaceutical research and development; product development consultation; consultancy relating to industrial research in the field of active pharmaceutical ingredients and new chemical entities; technical consultancy relating to product development; design and development of industrial products in the field of active pharmaceutical ingredients, drug substances in particular steroids, high potent substances, cannabinoids, antineoplastics; conducting of scientific feasibility studies; conducting of technical feasibility studies in the field of chemical research for the synthesis of existing and new chemical entities; chemical research; research relating to technology; development of new products for others; research and development for others with regard to new products; pharmaceutical research and development; scientific and industrial research in the field of active pharmaceutical ingredients, drug substances in particular steroids, high potent substances, cannabinoids, antineoplastics; laboratory research in the field of chemistry; industrial analysis and research services in the field of chemistry; preparation of scientific reports; preparation of technical reports relating to chemical research for the synthesis of existing and new chemical entities; engineering feasibility studies; development of new technology for others in the field of chemical, pharmaceutical, enzymatic reactions; development of industrial processes for others in the field of chemical, pharmaceutical, enzymatic reactions; development of new industrial products for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 16, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 2, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 2, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 2, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 22, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 22, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 16, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 10, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 29, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 29, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 9, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 21, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 21, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 12, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 12, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 12, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 30, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 30, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 30, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 23, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 19, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 18, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |